Stock listing

STXS Stock Price, News, Filings & Events — Stereotaxis, Inc.

Selected listing: STXS · AMEX · USD · US

This page tracks Stereotaxis, Inc.'s STXS:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following STXS:AMEX. STXS:AMEX is the stock-level entry point for investors researching Stereotaxis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Stereotaxis, Inc. is a public company traded under the ticker STXS in the American market, with a market capitalization of approximately $126.3 million. The company specializes in advanced robotic technologies for cardiac procedures. Stereotaxis aims to improve patient outcomes and enhance the efficiency of cardiac care through its innovative solutions.

STXS:AMEXUSDUSUpdated September 12, 2026
Stereotaxis, Inc. logo
Ticker
STXS:AMEX
Asset type
Stock
Market cap
$129.3M
Sector
Health Technology
Industry
Medical Specialties
Exchange
AMEX
Currency
USD

Stereotaxis, Inc. STXS:AMEX stock context

This page tracks Stereotaxis, Inc.'s STXS:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following STXS:AMEX. STXS:AMEX is the stock-level entry point for investors researching Stereotaxis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Stereotaxis, Inc. is a public company traded under the ticker STXS in the American market, with a market capitalization of approximately $126.3 million. The company specializes in advanced robotic technologies for cardiac procedures. Stereotaxis aims to improve patient outcomes and enhance the efficiency of cardiac care through its innovative solutions.

Latest news from Stereotaxis, Inc.

All Stereotaxis, Inc. news →

Stereotaxis, Inc. earnings calls

Research Stereotaxis, Inc.

Alternate listings